ABSTRACT. We describe a case of retinoblastoma with an atypical presentation and previously unreported cytogenetic aberrations. A 19-month-old girl with left intraocular retinoblastoma was treated with enucleation and chemotherapy. The disease showed aggressive evolution within a short period between diagnosis and relapse. Eight months after diagnosis, a new large tumor was present in the orbit of the right eye, with diffuse bone pain, pancytopenia and diffuse infiltration into the bone marrow and the central nervous system. The child did not respond to treatment and died. Cytogenetic studies made with G-banding, FISH and SKY analysis showed chromosomal aberrations commonly associated with retinoblastoma, including del(13q), i(6p),
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INTRODUCTION
Retinoblastoma (Rb) is the most common intraocular malignancy in childhood, with an annual incidence of 1/15,000-20,000 live births (Aerts et al., 2006) . It can be unifocal or multifocal, affecting one or both eyes at the same time, and it is termed sporadic or hereditary. It requires complex treatment, encompassing several therapeutic strategies in order to preserve life and eyesight .
Rb can infiltrate the brain via the optic nerve or the adjacent tissues, and thus, the disease can become extraocular (Chintagumpala et al., 2007) . Metastatic disease with no evidence of optic nerve involvement is rare. Lumbar puncture with cerebrospinal fluid analysis and bone marrow aspiration are not routinely performed. However, these tests are indicated in children with advanced intraocular disease or with evidence of extraocular disease at presentation (Melamud et al., 2006) . Rb can disseminate to other parts of the body including the bone marrow, although this rarely occurs, and it is generally scattered among normal elements (Khurshid et al., 2004) . Some tumors such as neuroblastoma and medulloblastoma can fully infiltrate the bone marrow and thus simulate acute leukemia (Inoue et al., 1974) . Nevertheless, when this pattern of disease occurs, it provides us the opportunity to examine directly the karyotype of the tumor cells. The specific cytogenetic abnormalities may also be of value in suggesting the diagnosis of the disease (Daly et al., 1987; Oliveros and Yunis, 1995) .
The present study describes an atypical case of a child with left intraocular Rb at diagnosis who was treated with enucleation prior to chemotherapy. However, eight months after diagnosis, a large tumor was present in the right orbit, along with diffuse bone pain, pancytopenia and diffuse infiltration into bone marrow and into the CNS. Cytogenetic analysis of bone marrow cells showed chromosomal aberrations common to Rb, such as del(13q), i(6p), +1, and monosomy 16, besides others not yet described, including dup(5q), dic(15;22) and add(14q).
CASE REPORT
A 19-month-old girl was admitted to our institution with leukocoria in the left eye in December 2003. Retina mapping showed a vascularized, white-mass tumor with points of calcification, occupying more than half of the retina and making it difficult to see the optic nerve. There was vitreous hemorrhage associated with endophytic and exophytic growth. Cranial computed tomography and magnetic resonance imaging revealed a localized left eye tumor. A histopathological study revealed an Rb that had surrounded the head of the optic nerve, but not beyond the lamina cribosa (Group V, Reese-Ellsworth classification) (Linn, 2005) . Laboratory tests, cerebrospinal fluid (CSF) and bone marrow showed no abnormalities.
The patient was treated with enucleation and chemotherapy in accordance with a Brazilian Retinoblastoma Protocol . The treatment was completed in May 2004, and she was followed up monthly. Four months after the end of the treatment, she was hospitalized with leg pain, lethargy, irritability, and a hardened tumor in the orbit of the right eye. A complete blood count revealed a low platelet count (49,000/mm³), and biochemical tests showed high levels of LDH (1033 IU). Cerebral tomography showed an extensive extra axial mass surrounding the frontal region. Anatomopathological examination of the tumor in the right orbit revealed the presence of malignant small-cell neoplasia and immunohistochemical tests were positive for S100 protein, synaptophysin, NSF, and GFAP, and negative for CD99 and NB84. Bone marrow showed a massive malignant infiltration of small round cells, with scarce and basophilic cytoplasm and few visible nucleoli. Immunophenotypic tests of tumors cells were negative for leukemia markers. Cytogenetic analysis by the G-banding disclosed the following: 47,XX,+1,dup(5)(q11.2;q35),+i(6p),del(13)(q12;q14),add (14) Figure 1A ). Fluorescent in situ hybridization (FISH) using a 6p probe (QBiogene) showed three signals: two normal 6p and one i(6p) in the five metaphases analyzed ( Figure 1B ). SKY analysis confirmed the abnormalities previously seen by G-banding and identified the origin of the marker chromosome as chromosome 1 ( Figure 1C ). The definitive karyotype found was 48,XX,+1,+1dup(5)(q11.2;q35),+i(6p),del(13)(q12;q14),add (14)(q32) (5)(q11.2;q35),+i(6) (p10),del(13)(q12;q14),add(14)(q32),dic(15;22)(p11.1;q13),-16,+mar [10] . B. FISH using 6p probe. Arrow indicates i(6p). C. SKY karyotype showing the inverted DAPI (left) and the classified (right) profiles for each chromosome. Extra copies of chromosome 1, where one of them has insertion of part of chromosome 3, ins(1;3)(q21;q26q29),dup(5) (q11.2;q35),+i(6)(p10),del(13)(q12;q14),t(14;16)(q32;q11.1),dic(15;22)(p11.1;q13, were indicated by arrows.
New cytogenetic aberrations in aggressive retinoblastoma
The child was treated for relapse with ifosfamide, carboplatin and etoposide. In February 2005, the child presented seizures and malignant cells infiltrating the spinal fluid. A new treatment was tried with carboplatin, vincristine and intrathecal chemotherapy, followed by cranial and neuraxial radiotherapy. In May 2005, the patient no longer responded to chemotherapy and died of progressive disease.
DISCUSSION
Since 1993, 125 Rb cases have been registered in our institution, but only one with bone marrow totally infiltrated by immature cells. Three similar cases have already been described in the literature and the diagnoses were based on histopathological and cytogenetic studies (Inoue et al., 1974; Daly et al., 1987; Khurshid et al., 2004) . The main cytogenetic alterations described in Rb are del(13), gain 1q and 6p, loss of 5q, and monosomy 16. Because few cases of Rb diffusely infiltrating in the bone marrow had been described, it is very difficult to know which cytogenetic alterations are involved and its relation to aggressiveness of disease.
The deletion of 13q is the alteration directly responsible for Rb, where the tumor suppressor gene RB1 is located, also i(6p) is important since it is the most common abnormality found in 50 to 60% of Rb cases. The presence of i(6p) may be an important genetic change in the development and progression of the tumor (Paderova et al., 2007) . Other regions such as 1q36 (E2F2 and ID3), 2p24-25 (ID2 and MYCN), 9p (p16), and 16p22 (E2F4) are also involved in the pRb pathway. Perhaps these regions contribute towards a third event that is necessary for completing the malignant transformation (Mairal et al., 2000; Chen et al., 2001) . The new cytogenetic abnormalities described in this case were duplication 5q, add(14q) and dic(15;22). It is possible that these changes played a role in the dissemination and progression of disease.
The atypical bilateral Rb case described here had an aggressive evolution with short period between diagnosis and relapse. The tumor cells did not respond to chemotherapy and the child died shortly afterwards. Certainly, the cytogenetic studies helped to diagnose the disease, but other cases of disseminated Rb need to be studied to clarify when cytogenetic abnormalities are present and to know whether they are present at the beginning of the disease, as well as determining their importance in the evolution of the disease.
